Profound Medical Corp (NAS:PROF)
$ 7.15 0.1 (1.42%) Market Cap: 209.63 Mil Enterprise Value: 188.61 Mil PE Ratio: 0 PB Ratio: 5.93 GF Score: 73/100

Q1 2020 Profound Medical Corp Earnings Call Transcript

May 07, 2020 / 08:30PM GMT
Release Date Price: $13.05 (+2.11%)
Operator

Greetings and welcome to the Profound Medical First Quarter 2020 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Stephen Kilmer, Investor Relations. Thank you. You may begin.

Stephen Kilmer
Profound Medical Corp. - IR

Good afternoon, everyone. Let me start by pointing out that this conference call will include forward-looking statements regarding Profound and its business, which may include, but is not limited to, expectations regarding the efficacy of Profound's technology in the treatment of prostate cancer, BPH, uterine fibroids and palliative pain. Often, but not always, forward-looking statements can be identified by the use of words such as plans, is expected, expects, scheduled, intends, contemplates, anticipates, believes, proposes or variations, including negative variations of such words or phrases, or state that certain actions, events or results may, could, would, might or will be taken, occur or be achieved. Such statements are based on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot